University of Cincinnati College of Medicine
- Consultant: AstraZeneca LP; Eli Lilly and Company; Forest Laboratories, Inc.; GlaxoSmithKline; Johnson & Johnson; Otsuka America Pharmaceutical, Inc.; Pfizer Inc; Repligen Corporation; Schering-Plough; Shire Pharmaceuticals Inc.; Somerset Pharmaceuticals, Inc.
- Grant Support: AstraZeneca LP; Bristol-Myers Squibb; Eli Lilly and Company; Forest Laboratories, Inc.; GlaxoSmithKline; Johnson & Johnson; Merck & Co., Inc.; Otsuka America Pharmaceutical, Inc.; Pfizer Inc; Repligen Corporation; Schering-Plough; Shire Pharmaceuticals Inc.; Somerset Pharmaceuticals, Inc.
- Research Funds: AstraZeneca LP; Eli Lilly and Company; Forest Laboratories, Inc.; GlaxoSmithKline; Johnson & Johnson; Otsuka America Pharmaceutical, Inc.; Pfizer Inc; Repligen Corporation; Schering-Plough; Shire Pharmaceuticals Inc.; Somerset Pharmaceuticals, Inc.
- Speakers Bureau: Bristol-Myers Squibb; Merck & Co., Inc.
- Travel Support to attend this meeting: Dey Pharma, L.P.